Saturday, October 16

InterCure to Present in Benzinga Cannabis Capital Conference

Article content

NEW YORK and TORONTO and HERZLIYA, Israel, Oct. 13, 2021 (GLOBE NEWSWIRE) — InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure” or the “Company”) today announced that Alexander Rabinovitch, CEO of InterCure, will present at the Benzinga Cannabis Capital Conference on Thursday, October 14, 2021 at 1:50pm ET. The presentation will be shown again on October 15 th at 1:50pm ET. In addition, Mr. Rabinovitch will participate in a live panel discussion titled, “International Spotlight – Continued Cannabis Expansion in European Markets” on Friday, October 15 at 2:10pm ET. To view the Company presentation, please click the following link: . To watch the live panel discussion, please click the following link: .

Article content

Management will be available for virtual one-on-one meetings with registered conference attendees. To register for the conference, please visit the conference website:

If you are interested in scheduling a one-on-one meeting with InterCure’s management team, please contact [email protected] .

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated “seed-to- sale” model to lead the fastest growing cannabis global market outside of North America.

For more information, visit: .

To be added to InterCure’s email distribution list, please email [email protected] with “InterCure” in the subject.


InterCure Ltd.
Amos Cohen, Chief Financial Officer
[email protected]

KCSA Strategic Communications
Investor and Media Relations
[email protected]

Primary Logo

Leave a Reply

Your email address will not be published. Required fields are marked *